How can we make sense of numerous instances of experts in politics, law enforcement, national security, military defense, fire arms, public health, culture, and history working closely with creators of scripted television series in the USA today? Why do TV makers need them? Why and how do these experts come to Hollywood? In order to answer these questions, I carried out a Bourdieusian field analysis of contemporary American TV series production, with a focus on how knowledge about political and social issues is produced and used in the TV industry. I identify four major expertise providers-the state, social movements, research organizations, and independent experts-and build a macro model of expertise exchange in the field of Hollywood TV. I argue that expertise in Hollywood is a form of capital which Hollywood professionals exchange for symbolic capital within the industry and in the field of power; it is also a form of capital that agents of the state, social movements, and research organizations exchange for symbolic capital in the field of power; and finally, independent experts trade their knowledge to accumulate economic and symbolic capital within the industry.
View Article and Find Full Text PDFAutoimmunity is still a mystery of clinical immunology and medicine as a whole. The etiology and pathogenesis of autoimmune disorders remain unclear and, thus, are assessed as a balance between hereditary predisposition, triggering factors and the appearance of autoantibodies and/or self-reactive T cells. Among the immunological armamentarium, molecular mimicry, based on self-reactive T- and B-cell activation by cross-reactive epitopes of infectious agents, is of special value.
View Article and Find Full Text PDFAim: To develop a conceptual model of using catalytic autoantibodies as diagnostic and monitoring tools in organ-specific autoimmune disorders.
Material And Methods: A total of 99 patients (56 males and 43 females aged 21-52 years) with autoimmune myocarditis (AM) and 198 patients (77 males and 121 females aged 8-79 years) with autoimmune uveitis (A U) participated in the study. AM patients were examined for anticardiomyosin and anti-DNA autoantibodies (ACM, ADNAab), AU patients - for autoantibodies to S-antigen, IRBP, redopsin, phosphocine, autoDNA.